ストックスクリーナーアプリを入手
1.22
5.43%
-0.07
アフターアワーズ：
1.23
0.01
+0.82%
Alx Oncology Holdings Inc (ALXO) 最新ニュース
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update - Defense World
ALX Oncology FY2024 EPS Forecast Raised by Cantor Fitzgerald - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Sees Significant Decrease in Short Interest - MarketBeat
Brokers Set Expectations for ALX Oncology FY2024 Earnings - MarketBeat
Former Mirati CMO Alan Sandler joins ALX Oncology - The Pharma Letter
Data-Based Insights About XBP Europe Holdings Inc (XBP) - Stocks Register
New Outlook On Celsius Holdings Inc - Stocks Register
ALX Oncology Strengthens Leadership with Key Appointment - TipRanks
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer - GlobeNewswire
ALX Oncology Appoints Former Mirati & Genentech Exec as Chief Medical Officer | ALXO Stock News - StockTitan
Cantor Fitzgerald Reiterates Overweight Rating for ALX Oncology (NASDAQ:ALXO) - Defense World
ALXO stock touches 52-week low at $1.31 amid market challenges - Investing.com
FMR LLC's Strategic Reduction in ALX Oncology Holdings Inc Shares - GuruFocus.com
Analysts Offer Predictions for ALX Oncology FY2028 Earnings - MarketBeat
ALX Oncology Highlights Promising Trial Results - TipRanks
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
ALX Oncology Announces November Investor Conference Participation - GlobeNewswire
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
ALXOALX Oncology Holdings Inc. Latest Stock News & Market Updates - StockTitan
ALX Oncology Announces Results from Phase 1b/2 Trial of - GlobeNewswire
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 - StockTitan
ALXO stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia
ALXO stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa
SG Americas Securities LLC Has $50,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Down 6.7% in September - MarketBeat
Technical analysis of Alx Oncology Holdings Inc (ALXO) stock chart patterns - US Post News
ALXO Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Closing Figures: Alx Oncology Holdings Inc (ALXO)’s Negative Finish at 1.44, Down -11.11 - The Dwinnex
SVP, FINANCE AND CAO Pinto Shelly sale 564 shares of Alx Oncology Holdings Inc [ALXO] - Knox Daily
Millennium Management LLC Reduces Stake in ALX Oncology Holdings Inc - Yahoo Finance
ALXO stock touches 52-week low at $1.55 amid market challenges By Investing.com - Investing.com South Africa
ALXO stock touches 52-week low at $1.55 amid market challenges - Investing.com
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $12.20 Average PT from Brokerages - MarketBeat
ALX Oncology Holdings Drops To US$1.68, Yet Insiders May Have Sold Too Early - Simply Wall St
American Century Companies Inc. Cuts Stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
A company insider recently sold 564 shares of Alx Oncology Holdings Inc [ALXO]. Should You Sale? - Knox Daily
ALX Oncology Chief Medical Officer resigns, search for replacement begins - Investing.com India
Point72 Asset Management L.P. Makes New $1.83 Million Investment in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology CMO Sophia Randolph Announces Resignation - TipRanks
ALX Oncology Chief Medical Officer resigns, search for replacement begins By Investing.com - Investing.com UK
ALX Oncology Holdings Inc. Announces Resignation of Sophia Randolph as Chief Medical Officer, Effective October 11, 2024 - Marketscreener.com
Point72 Asset Management L.P. Acquires New Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - MarketBeat
ALXO stock touches 52-week low at $1.75 amid market challenges By Investing.com - Investing.com South Africa
ALXO stock touches 52-week low at $1.75 amid market challenges - Investing.com
Marshall Wace LLP Has $3.83 Million Stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
You might want to take a look at Alx Oncology Holdings Inc (ALXO) now - SETE News
Renaissance Technologies LLC Increases Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
ALXO’s 2023 Market Dance: Down -87.78% – Time to Invest? - The InvestChronicle
Alx Oncology Holdings Inc (ALXO)’s results reveal risk - US Post News
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):